Kinnate Biopharma Inc. - stock earnings
KNTE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -30.7 million USD | ? USD |
| 2023Q2 | -31.9 million USD | ? USD |
| 2023Q1 | -31.2 million USD | ? USD |
| 2022Q4 | -29.9 million USD | ? USD |
| 2022Q3 | -30.1 million USD | ? USD |
| 2022Q2 | -26.7 million USD | ? USD |
| 2022Q1 | -26.7 million USD | ? USD |
| 2021Q4 | -26.2 million USD | ? USD |
| 2021Q3 | -24.7 million USD | ? USD |
| 2021Q2 | -21.4 million USD | ? USD |
| 2021Q1 | -17.5 million USD | ? USD |
| 2020Q4 | -13.7 million USD | ? USD |
| 2020Q3 | -10.5 million USD | ? USD |
| 2020Q2 | -7.6 million USD | ? USD |
| 2020Q1 | -3.9 million USD | ? USD |
| 2019Q4 | -3.9 million USD | ? USD |
KNTE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -127.2 million USD | ? USD |
| 2022 | -114.0 million USD | ? USD |
| 2021 | -89.4 million USD | ? USD |
| 2020 | -35.4 million USD | ? USD |
| 2019 | -11.9 million USD | ? USD |
| 2018 | -7.6 million USD | ? USD |
KNTE
Price: $2.65
52 week price:
Earnings Per Share: -2.78 USD
P/E Ratio: -0.84
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 55200
Market Capitalization: 125.0 million